Developing a programme grant: the importance of feasibility work to inform design and conduct Dr Rachel Taylor Research Associate University College London.

Slides:



Advertisements
Similar presentations
Diabetes and the Health Innovation Network Charles Gostling 19 September, 2013.
Advertisements

South West Specialised Commissioning Group Selena Blake – Senior Commissioning Manager / TYA Programme Manager South West Specialised Commissioning Group.
Experiences of Patient and Public involvement in the Research Process Roma Maguire Senior Research Fellow Cancer Care Research Team School of Nursing and.
Carrol Gamble Jenny Newman Heather Bagley Bec Hanley.
Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London.
Teaching/Learning Strategies to Support Evidence-Based Practice Asoc. prof. Vida Staniuliene Klaipeda State College Dean of Faculty of Health Sciences.
Improving health outcomes across England by providing improvement and change expertise How to Measure Patient Activation Measuring Patient Activation In.
Authors and affiliation Research, University of Sheffield, 3 East Midlands Ambulance Service Study flow Conclusion In addition to measures relating to.
Health service utilization by patients with common mental disorder identified by the Self Reporting Questionnaire in a primary care setting in Zomba, Malawi.
BALANCING EFFICIENCY AND EQUITY A NEW INTERNATIONAL RESEARCH PROGRAMME ADDRESSING THE ROLE OF VALUES IN HEALTH CARE Department of Primary Care and Public.
© Nuffield Trust Inner North West London Integrated Care Pilot – year one evaluation 8 July 2013 Holly Holder Fellow in health policy Ian Blunt Senior.
MDS National Survey Assessing the needs for support Monika Janosik MDS UK Project Worker The Lancaster Hotel London 3 rd October 2014.
Creating Better Health and Care Services An overview of a Better Health and Care Review process.
Recruitment to Trials. Background Recruitment of participants is a VERY important issue. The general consensus is that most trials under recuit.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
How do nurses use new technologies to inform decision making?
Modelling the impact of service innovation in Stroke Care Tanaka Business School: Imperial College. Lead researcher: Dr Benita Cox Background Stroke is.
Improving the Health and Wellbeing of People with Learning Disabilities: An Evidence-Based Commissioning Guide for Clinical Commissioning Groups Dr Matt.
CLINICAL GOVERNANCE and MI Services : An introduction National MI Training Course University of Leicester 5 th July 2007 Mark Cheeseman E ast Anglia MI.
18 th to 21 st June 2013 Primary Care Sciences Keele University RUNNING RANDOMISED CLINICAL TRIALS For further enquiries contact Debbie Cooke Tel: +44(0)1782.
Acute Quality Standards Dan Beckett Acute Physician CMO Advisor for Acute & General Medicine.
National Obesity Observatory The Standard Evaluation Framework National Obesity Observatory The Standard Evaluation Framework Kath Roberts
Medical Audit.
CArers of people with Dementia: Empowerment and Efficacy via Education (CAD: E 3 ) A multi-disciplinary study of the impact of educational interventions.
Systematic Reviews.
National Cancer Survivorship Initiative - Models of Care The South West Regional CYP Oncology Shared Care Network.
Introduction to the HEART UK FH Toolkit Dr Jonathan Morrell, Chair, FHGIT Dr Dermot Neely, Chair, Medical Scientific & Research Committee.
CTxCPCRN Central Texas Cancer Prevention and Control Research Network Kick Off Grantee Meeting Atlanta, Georgia October 15-16, 2009.
Objective the aim of this project was directly addressing a major health problem for Jordan by producing a guideline as a pilot in which the strengths.
Evaluation, Trials and Studies Coordinating Centre Developing Sight Loss and Vision research questions: a funder’s perspective Anna Tallant Scientific.
Hayat Mushcab, B.Sc. M.Sc. W. George Kernohan, PhD Jonathan Wallace B.A., M.Sc. Roy Harper, M.D, and Suzanne Martin, PhD THE JOURNEY TOWARDS SUCCESSFUL.
Bromley & Bexley Pathfinder Whole System Change ‘Bringing It All Together’ 15 th October 2012 London Regional SEND Conference Helen Norris, Head of Specialist.
Faith Gibson Clinical Professor of Children and Young People’s Cancer Care Great Ormond Street Hospital for Children NHS Foundation Trust and London South.
The role of feasibility and scoping studies in the development of the programme grant: Does specialist teenage and young adult cancer care improve outcome?
NIHR RP-PG Steps in the development of a patient- reported outcome measure for teenage and young adults with cancer: The BRIGHTLIGHT survey.
Dr Rachel Taylor University College London & London South Bank University On behalf of the ‘Essence of Care’ research team.
BRIGHTLIGHT: emerging results Dr Rachel Taylor on behalf of the BRIGHTLIGHT Team.
Teenage and young adult (TYA) cancer services: who, where and what? Dr Rachel Taylor PhD Senior Research Associate, University College London and South.
Tom Grew NCRI CSG TYA CCG On behalf of the ‘Essence of Care’ research team.
BRIGHTLIGHT The 2012 TYA cancer cohort Study Professor Jeremy Whelan Professor of Cancer Medicine and Consultant Oncologist Dr Lorna Fern NCRI Teenage.
Development of a patient- reported outcome measure for TYA with cancer: the BRIGHTLIGHT survey Dr Rachel Taylor on behalf of the BRIGHTLIGHT team.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
NIHR RP-PG A multi-faceted approach to collaboration: The BRIGHTLIGHT: experience Dr Rachel Taylor & Dr Lorna Fern on behalf of the BRIGHTLIGHT.
NIHR Themed Call Prevention and treatment of obesity Writing a good application and the role of the RDS 19 th January 2016.
HTA Efficient Study Designs Peter Davidson Head of HTA at NETSCC.
UK Clinical Sarcoma Research. Changes in UK Appointment of Cancer Tsar Use of NICE to evaluate care pathways and technology/drugs Minimum datasets established.
PREPARED BY The New Zealand Cancer Nurse Coordinator Initiative Natalie James National Nurse Lead May 2013.
Standards and Competencies for Cancer Chemotherapy Nursing Practice in Canada: CANO/ACIO AN INTRODUCTION.
1 6 th National Children & Young People Survivorship Workshop A GP perspective Una Macleod Professor of Primary Care Medicine Primary care cancer lead,
Template produced at the Graphics Support Workshop, Media Centre Background There is no evidence to suggest that people with dementia experience any less.
What data are available, and how are they accessed?
Welcome to Southern Health Southern Health exists to improve the health, wellbeing and independence of the people we serve.
‘The right healthcare, for you, with you, near you’ End of Life Care Snapshot of National Publications.
Asthma - diagnosis and monitoring guideline: primary care implementation feasibility project update Adoption & Impact Programme, NICE: Sally Chisholm,
Research and Development Dr Julie Hankin Medical Director.
DATA COLLECTION METHODS IN NURSING RESEARCH
RUNNING RANDOMISED CLINICAL TRIALS
The DEPression in Visual Impairment Trial:
RCPCH & RCN Annual Conference
Starting out on a clinical academic pathway: the experience of a newly- qualified nurse Sarah Lea Faculty of Health and Social Care, London South Bank.
BRIGHTLIGHT: from first glow to now – what, why and how
Amanda Lilley-Kelly Senior Trial Co-ordinator
Professor Stephen Pilling PhD
Progressing Disability Services for Children and Young People
NICE -The End of Life Care (Service Delivery) Guideline for adults in the last year of life. NICE’s aim is to improve outcomes for people who use the.
Communicating About Clinical Trials
Rachel Taylor, Ana Martins, Sarah Lea, Jeremy Whelan, Lorna Fern
Faith Gibson Workstream 1 Lead
The impact of small-group EBP education programme: barriers and facilitators for EBP allied health champions to share learning with peers.
Dunleavy G1, Posadzki PP1, Kyaw BM2, Car J 1, 3.
Presentation transcript:

Developing a programme grant: the importance of feasibility work to inform design and conduct Dr Rachel Taylor Research Associate University College London & London South Bank University

Why the Essence of Care study? Teenage and Young Adult (TYA) cancer care experience relatively unknown Poorer outcomes in 15 – 24 year olds compared to children Increased interest in specialist TYA cancer care  NICE Children & Young people’s Improving Outcome Guidance  Internationally Critically asking for evidence of outcomes associated with TYA care

Aim To determine whether specialist TYA cancer care in England, for young people aged 13 – 24 years, is associated with improved outcomes during and after treatment BUT…

Challenges What study design?  Ideally randomised controlled trial, BUT Services are already in place Unethical to randomise to specialist care vs. not Variation in services across country What sample?  Too much variability to be single centre  National cohort, BUT How do you identify ALL young people? How do you recruit ALL young people? What outcomes?

Solution Feasibility studies

MRC framework for evaluating complex interventions

Essence of Care: Phase I

Study 1: Current & future policy underpinning TYA cancer Semi-structured interviews with four commissioners of TYA cancer services Documentary analysis of implementation plans  Progress reports from Sept ‘08 to Nov ‘09

What this informed… Aspects of study design:  Multi-centre, national

Study 2: Nature of TYA cancer care Non-participant observation  Single principle treatment centre  Observation over 2 weeks  All areas providing TYA cancer care Semi-structured interviews  Three health care professionals  Three young people

What this informed… Observation schedule for a multiple case study using non-participant observation Guided the sampling strategy for a multiple case study

Studies Study 3: Towards a definition of TYA cancer care unit Study 4: Identifying the professional competencies for TYA cancer care Study 5: Young people’s experiences of cancer care  Workshops with young people and health professionals

Workshop participants Young people n = 11 (4 CCG) Age at diagnosis:  13 – 25 years Current age:  16 – 29 years All off treatment Health Care Professionals Two workshops n = 22 Clinical leads = 5 Doctors = 2 Nurses = 9 Other = 6

Study 3: Towards a definition of TYA cancer care unit Included in both young person and health professional workshop + ‘Find Your Sense of Tumour’ 2010 conference ‘Pyramid of importance’  Key features of a TYA cancer unit (identified from literature) + blank cards  Rank according to importance on a pyramid  Features given a rank score according to placement in pyramid

What this informed… Importance of involving young people if researching ‘experience’  Involve young people in study design  Involve young people in study conduct

Study 4: Identifying the professional competencies for TYA cancer care Included in the health professional workshop Diamond ranking  61 key skills, knowledge, attitudes (identified from a review of the literature) + blank cards  Rank on a diamond  Focus on the top half of the pyramid

What this informed… Highlighted the pattern of communication in TYA healthcare Initial survey for an international Delphi survey

Study 5: Young people’s experiences of cancer care Included in the workshop with young people Peer interviews  Conducted by the CCG (young person user group)  Concluded with a newspaper headline Spider diagram  Expansion of headlines through group discussion Group analysis with the CCG using thematic analysis of headlines & transcripts

What this informed… Quality of life as important as survival  Implication for primary outcome Basic framework for the Essence of Care Survey

Study 6: Self-reported outcome after treatment for cancer Literature review  Search terms related to outcome, i.e., quality of life  Cochrane + 4 databases  Young people aged 13 – 45 years with cancer (US definition of ‘young adult’)  Any study design  Study quality assessed with Cesario/CONSORT/STROBE guidelines

What this informed… Identify significant non-medical outcomes Understand young people’s experiences of cancer [care]  Underpin content of the Essence of Care Survey

Study 7: Outcome measures validated for young people aged 13 – 24 years Literature review  Search terms related to outcome, i.e., quality of life  Cochrane + 4 databases  Participants <16 years and ≥19 years  Only quantitative designs  Instrument quality assessed with McMaster Outcome Measure Rating Form

What this informed… Identify outcome measures that can be used in the Essence of Care study Develop a toolkit of outcome measures used in TYA, with a validity & reliability profile, for use in future research

Study 8: Evaluation of NHS datasets Aims  Identify young people within 90 days of diagnosis  To provide clinical data Review national datasets Criteria:  Population based  Minimum data: NHS number, name, gender, age, address, diagnosis & place of care

Results: identification of a dataset

What this informed… Cancer Waiting Time dataset had overall completeness of 99%  Young people can be identified within 90 days Only suspected therefore needs confirmation Additional data in other datasets  Clinical data available without relying on medical notes Quality of data is not confirmed Missing data Lack of reliable death data

Study 9: Young people’s preference for participation in a longitudinal study Recruitment in two principal treatment centres Six young people aged 17 – 21 years Complete outcome measures  PedsQL, INPATSAT, HUI2, EQ5D Semi-structured interviews

What this informed… Primary and secondary outcome measures Study design issues Importance of involving young people in study design

Study 10: Framework for the Essence of Care study Challenges for Phase II  Can we identify all newly diagnosed young people in England in 2012?  How can they be recruited??????  How can data be collected?????? Yes

Solutions NIHR funded project = access to NCRN nurses  Will they recruit young people? Search existing national cohort studies (e.g. Millennium Cohort Study) How do they data collect?  Commercial research companies  Is this economically feasible? Yes

The 2012 TYA Cancer Cohort Study UCLH: Dr Jeremy Whelan (CI) Susie Pearce Martin Lerner UCL: Dr Julie Barber Professor Steve Morris Professor Rosalind Raine Dr Rachel Taylor University of Leeds: Dr Richard Feltbower St James’ University Hospital Dr Dan Stark Cancer Research UK Dr Lorna Fern GOSH/LSBU Professor Faith Gibson NCAT Louise Hooker NWCIS Dr Tony Moran Dr Catherine O’Hara NCRI CSG TYA CCG: Hannah Millington

Workstream 1: the description of specialist TYA cancer care Explore the culture of care through non- participant observation, interviews and documents analysis Identify the specialist competencies and added value of specialist health professionals through a Delphi survey Validate a bespoke scale to categorise 3 levels of TYA care (TYA Cancer Specialism Scale)

Workstream 2: cohort study of all TYA diagnosed during an 18 month period Accrual within 3 months of diagnosis and follow- up will continue for 3 years Relate the level of specialist care received to:  Patient reported outcome  Clinical processes and outcomes  Experience of cancer care  Achieving social and educational milestones  Geographic and socio-demographic inequalities

Workstream 3: health economics Compare costs to the NHS and personal social services between TYA receiving different levels of specialist care Estimate the cost to TYA and families of specialist care Calculate the cost effectiveness of different levels of TYA care Workstream 4: intervention development & service evaluation

Summary Complex evaluation of health care need complex study designs MRC framework for evaluating complex interventions  Importance of feasibility & pilot studies NIHR recognition  Programme development grant

Conclusion So how did we do?  Stage 1 submission: March 2010  Reviewer feedback: May 2010  Stage 2 submission: October 2010  Sub-panel comments: March 2011  Amended submission: May 2011 Outcome?

Dr Lorna Fern Professor Faith Gibson Dr Catherine O’Hara Susie Pearce Dr Rachel Taylor Dr Jeremy Whelan Research team: Phase I NCRI Clinical Studies Group Teenage & Young Adult Core Consumer Group  James Ashton  Katie Brooman  Tom Grew  Hannah Millington  Carol Starkey

Acknowledgements Teenage Cancer Trust for funding the ‘Essence of Care’ project Carol Irving & David Wright for their support with the CCG Professor Ian Lewis, Dr David Hobin & members of TYAC for permission to work with their data Participants & Steering Committee of ‘Find Your Sense of Tumour’